EP Patent

EP1011728A1 — Prostaglandin product

Assigned to Alcon Research LLC · Expires 2000-06-28 · 26y expired

What this patent protects

A pharmaceutical product comprising an aqueous prostaglandin formulation and a polypropylene container are disclosed. Aqueous prostaglandin formulations are more stable in polypropylene containers than polyethylene containers.

USPTO Abstract

A pharmaceutical product comprising an aqueous prostaglandin formulation and a polypropylene container are disclosed. Aqueous prostaglandin formulations are more stable in polypropylene containers than polyethylene containers.

Drugs covered by this patent

Patent Metadata

Patent number: EP1011728A1
Jurisdiction: EP
Classification: —
Expires: 2000-06-28
Drug substance claim: No
Drug product claim: No
Assignee: Alcon Research LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.